{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:04:02Z","timestamp":1789563842192,"version":"build-2803163510"},"reference-count":67,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016387","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:13:21Z","timestamp":1789560801000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological lipid-lowering therapies for primary and secondary prevention of cardiovascular disease in adults with dyslipidaemia: a systematic review and network meta-analysis"],"prefix":"10.1002","volume":"2026","author":[{"given":"Kamyar","family":"Shokraee","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Germany\/UK, D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society; Medical Faculty of the Heinrich-Heine-University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Bongaerts","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Germany\/UK, D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society; Medical Faculty of the Heinrich-Heine-University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petek Eylul","family":"Taneri","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Germany\/UK, D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society; Medical Faculty of the Heinrich-Heine-University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Micaela","family":"Escobar Liquitay","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Iberoam\u00e9rica, Research Department; Universidad del Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavosh","family":"Olfati","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Mihaela","family":"Zorger","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-899X","authenticated-orcid":false,"given":"Juan VA","family":"Franco","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Germany\/UK, D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society; Medical Faculty of the Heinrich-Heine-University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"22","key":"10.1002\/14651858.CD016387-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023","volume":"86","author":"Stark","year":"2025","journal-title":"JACC"},{"issue":"10","key":"10.1002\/14651858.CD016387-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1016\/s2214-109x(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","author":"Kaptoge","year":"2019","journal-title":"Lancet Global Health"},{"issue":"42","key":"10.1002\/14651858.CD016387-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"European Heart Journal"},{"issue":"32","key":"10.1002\/14651858.CD016387-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD016387-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/circresaha.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circulation Research"},{"issue":"9438","key":"10.1002\/14651858.CD016387-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"10226","key":"10.1002\/14651858.CD016387-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD016387-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"e002640","DOI":"10.1136\/bmjgh-2020-002640","article-title":"Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries","volume":"5","author":"Chow","year":"2020","journal-title":"BMJ Global Health"},{"issue":"2","key":"10.1002\/14651858.CD016387-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"e0002905","DOI":"10.1371\/journal.pgph.0002905","article-title":"Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries","volume":"4","author":"Li","year":"2024","journal-title":"PLOS Global Public Health"},{"issue":"25","key":"10.1002\/14651858.CD016387-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"e1082\u2013e1143","DOI":"10.1161\/cir.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/apha\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"8","key":"10.1002\/14651858.CD016387-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Canadian Journal of Cardiology"},{"issue":"25","key":"10.1002\/14651858.CD016387-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD016387-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.cir.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD016387-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/vhrm.s33664","article-title":"Ezetimibe therapy: mechanism of action and clinical update","volume":"8","author":"Toth","year":"2012","journal-title":"Vascular Health and Risk Management"},{"key":"10.1002\/14651858.CD016387-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1028355","DOI":"10.3389\/fcvm.2022.1028355","article-title":"Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome","volume":"9","author":"Biolo","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"S1","key":"10.1002\/14651858.CD016387-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.3909\/ricm19s1s0002","article-title":"PCSK9 inhibitors: mechanism of action, efficacy, and safety","volume":"19","author":"Roth","year":"2018","journal-title":"Reviews in Cardiovascular Medicine"},{"key":"10.1002\/14651858.CD016387-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1260921","DOI":"10.3389\/fphar.2023.1260921","article-title":"Inclisiran: a new generation of lipid-lowering siRNA therapeutic","volume":"14","author":"Zhang","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"19","key":"10.1002\/14651858.CD016387-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/01.cir.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD016387-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/circgenetics.114.000952","article-title":"Effect of bile acid sequestrants on the risk of cardiovascular events","volume":"8","author":"Ross","year":"2015","journal-title":"Circulation: Cardiovascular Genetics"},{"issue":"1","key":"10.1002\/14651858.CD016387-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s43856-025-01124-x","article-title":"Pleiotropic effects between statin intake and inflammation parameters in two distinct population-based studies","volume":"5","author":"Freuer","year":"2025","journal-title":"Communications Medicine"},{"issue":"1","key":"10.1002\/14651858.CD016387-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"25","key":"10.1002\/14651858.CD016387-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/nejmoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.1002\/14651858.CD016387-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/nejmoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"10.1002\/14651858.CD016387-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/nejmoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD016387-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/nejmoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD016387-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/fjc.0000000000001053","article-title":"Inclisiran: a novel agent for lowering apolipoprotein B-containing lipoproteins","volume":"78","author":"Warden","year":"2021","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD016387-BIB0027|cit27","unstructured":"World Health Organization (WHO) HEARTS: technical package for cardiovascular disease management in primary health care: risk-based CVD management https:\/\/www.who.int\/publications\/i\/item\/9789240001367 2020"},{"issue":"1","key":"10.1002\/14651858.CD016387-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016387-BIB0029|cit29","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016387-BIB0030|cit30","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"issue":"11","key":"10.1002\/14651858.CD016387-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD016387-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jacl.2024.09.014","article-title":"Time to benefit of intensive lipid lowering therapy in individuals with cardiovascular disease","volume":"19","author":"Li","year":"2025","journal-title":"Journal of Clinical Lipidology"},{"issue":"22","key":"10.1002\/14651858.CD016387-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jacc.2008.08.039","article-title":"Primary prevention of cardiovascular mortality and events with statin treatments","volume":"52","author":"Mills","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD016387-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/cvm-2-5-205","article-title":"Withdrawal of cerivastatin from the world market","volume":"2","author":"Furberg","year":"2001","journal-title":"Trials"},{"issue":"16","key":"10.1002\/14651858.CD016387-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/nejmoa1701488","article-title":"Cardiovascular efficacy and safety of bococizumab in high-risk patients","volume":"376","author":"Ridker","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD016387-BIB0036|cit36","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Technical supplement to Chapter 4: Searching for and selecting studies (chapter last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016387-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016387-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jclinepi.2021.01.006","article-title":"An evaluation of Cochrane Crowd found that crowdsourcing produced accurate results in identifying randomized trials","volume":"133","author":"Noel-Storr","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016387-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jclinepi.2020.11.003","article-title":"Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane Reviews","volume":"133","author":"Thomas","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016387-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jclinepi.2020.08.008","article-title":"Cochrane Centralised Search Service showed high sensitivity identifying randomized controlled trials: a retrospective analysis","volume":"127","author":"Noel-Storr","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016387-BIB0041|cit41","unstructured":"Covidence Veritas Health Innovation 2026"},{"key":"10.1002\/14651858.CD016387-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016387-BIB0043|cit43","unstructured":"Claude 4.6 Sonnet [large language model]. https:\/\/claude.ai\/ Anthropic 2026"},{"issue":"3","key":"10.1002\/14651858.CD016387-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016387-BIB0045|cit45","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook 2023"},{"key":"10.1002\/14651858.CD016387-BIB0046|cit46","unstructured":"Higgins JP Savovi\u0107 J Page MJ Sterne JA on behalf of the RoB2 Development Group Excel tool to implement RoB2 https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool"},{"key":"10.1002\/14651858.CD016387-BIB0047|cit47","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016387-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD016387-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bmjebm-2022-112102","article-title":"Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane","volume":"28","author":"Flemyng","year":"2023","journal-title":"BMJ Evidence-Based Medicine"},{"key":"10.1002\/14651858.CD016387-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Wilkinson J Heal C Flemyng E Antoniou GA Aburrow T Alfirevic Z INSPECT-SR: a tool for assessing trustworthiness of randomised controlled trials medRxiv [Preprint] 2025 10.1101\/2025.09.03.25334905","DOI":"10.1101\/2025.09.03.25334905"},{"key":"10.1002\/14651858.CD016387-BIB0051|cit51","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (chapter last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016387-BIB0052|cit52","unstructured":"Chaimani A Caldwell DM Li T Higgins JP Salanti G Chapter 11: Undertaking network meta-analyses (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016387-BIB0053|cit53","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis (chapter last updated August 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016387-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016387-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Research Synthesis Methods"},{"issue":"3","key":"10.1002\/14651858.CD016387-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/bimj.201800167","article-title":"Network meta-analysis of multicomponent interventions","volume":"62","author":"R\u00fccker","year":"2019","journal-title":"Biometrical Journal"},{"key":"10.1002\/14651858.CD016387-BIB0057|cit57","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD016387-BIB0058|cit58","unstructured":"Schwarzer G Carpenter JR Rucker G Meta-analysis with R New York Springer International Publishing"},{"issue":"414","key":"10.1002\/14651858.CD016387-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016387-BIB0060|cit60","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD016387-BIB0061|cit61","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2026"},{"issue":"1","key":"10.1002\/14651858.CD016387-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD016387-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD016387-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nu\u00f1ez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD016387-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016387-BIB0066|cit66","unstructured":"Grammarly Grammarly, Inc 2026"},{"key":"10.1002\/14651858.CD016387-BIB0067|cit67","unstructured":"ChatGPT 5.2\/5.5 [large language model]. \/openai.com\/ OpenAI 2026"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:13:33Z","timestamp":1789560813000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016387"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016387","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}